Trust in COVID-19 Vaccine Shifts 67%, Medisafe Reports

Respondents are eager to take the vaccine despite concerns over side-effects and distribution challenges

January 28, 2021, Boston, MA – Results from a new Medisafe survey of more than 4,000 patients reveal new confidence in the COVID-19 vaccine, with 80% of respondents placing trust in the shot, compared to just 13% of patients surveyed in October 2020. The new Medisafe survey aimed to examine patients’ feelings about entering year two of the pandemic, the COVID-19 vaccine, and the impact of the virus.

You may also like

Enhancing Multiple Sclerosis Patient Outcomes Through Digital Engagement

Multiple Sclerosis (MS) represents a formidable challenge in healthcare, a chronic, often unpredictable disease of the central nervous system that 

..Read More

Boosting Diabetes Adherence: Medisafe Digital Tools Deliver Results

Summary Managing diabetes presents significant challenges both for patients and pharmaceutical companies. Adherence to medication regimens, continuous monitoring, and lifestyle 

..Read More

High-Stakes GLP-1s: Where Digital Reinforcement Becomes Mission-Critical

Today’s groundbreaking announcement from Novo Nordisk and Eli Lilly to reduce the cost of their blockbuster weight loss drugs in 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.